2.05
2.05 (-1.11%)
As of Jun 14, 2022
In8bio, Inc. [INAB]
Source:
Company Overview
In8bio, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | (646) 600-6438 |
| Industry | manufacturing |
| CEO | William Ho |
| Website | www.in8bio.com. |